Skip to main content
Clinical Trials/NCT01428947
NCT01428947CompletedNot Applicable

Study of Cognitive Function Before and After Coronary Angiography

Karolinska Institutet1 site in 1 country80 target enrollmentStarted: September 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
80
Locations
1
Primary Endpoint
Change in cognitive dysfunction from baseline to two days after coronary angiography

Study Overview

Brief Summary

The purpose of the study is to study if coronary angiography cause cognitive dysfunction.

Detailed Description

We have previously shown, using transcranial doppler, that coronary angiography cause cerebral microembolism. Cerebral microemboli were more common using the radial than femoral approach. Previously, cerebral microembolism has been associated with new cerebral lesions on MRI. The clinical significance of these new lesions is not determined. The primary aim of this pilot study is to see if coronary angiography cause cognitive dysfunction determined by the MoCA-test. A secondary aim is to relate cognitive dysfunction to cerebral microembolism measured by transcranial doppler. A third aim is to study potential differences between the femoral and radial approaches.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
35 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Elective coronary angiography irrespective of cause

Exclusion Criteria

  • •Previous CABG, language problems, not willing to participate

Outcomes

Primary Outcomes

Change in cognitive dysfunction from baseline to two days after coronary angiography

Time Frame: Baseline and two days

The Montreal Cognitive Assesment test will be performed before, 2 and 30 days after coronary angiography

Secondary Outcomes

  • Number of patients with cerebral microemboli(Baseline)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Per Tornvall

Docent

Karolinska Institutet

Study Sites (1)

Loading locations...

Similar Trials